Marcel Suleiman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marcel Suleiman has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Yves Choffat
Department of Evolutionary Biology and Environmental Studies University of Zurich Zürich Switzerland
6 shared publicationsFrancesca Demaria
Institute for Chemistry and Bioanalytics, FHNW University of Applied Sciences and Arts Northwestern, Muttenz, Switzerland
4 shared publicationsCristina Zimmardi
FHNW University of Applied Sciences and Arts Northwestern Switzerland
3 shared publicationsOwen L. Petchey
Department of Evolutionary Biology and Environmental Studies University of Zurich Zürich Switzerland
3 shared publicationsPhilippe Corvini
Institute for Chemistry and Bioanalytics, FHNW University of Applied Sciences and Arts Northwestern, Muttenz, Switzerland
3 shared publicationsUriah Daugaard
3 shared publications
Latest Publications
- Open Access
Coupling Complementary Pathways in a Bacterial Co-culture Enables 4-Aminophenol Removal during Paracetamol Degradation
Pharmaceutical biodegradation can generate potentially toxic metabolites that persist after the parent compound has been removed, posing additional risks to aquatic environments. Microbial co-cultures offer a promising strategy to address this challenge by combining complementary metabolic capabilities to remove both pharmaceuticals and their harmful transformation products by coupling complementary degradation pathways. Here, we investigated a two-species co-culture combining the paracetamol-degrading bacterium Delftia P1 with Microbacterium lacus to enable subsequent 4-AP removal. While Delftia P1 efficiently degraded paracetamol, it accumulated 4-AP as a dead-end metabolite. M. lacus was selected to complement this metabolic limitation because its genome contains a homolog of sadB, a monooxygenase gene involved in 4-AP transformation. The relative abundance of the two strains strongly influenced 4-AP removal, with the highest efficiency achieved at a Delftia P1:M. lacus cell-density ratio of 1:100, corresponding to an OD600nm ratio of 1:10. At this ratio, the co-culture achieved complete removal of paracetamol and 4-AP within 6 and 24 h, respectively. Its capacity was tested in wastewater, where 100% of paracetamol were removed within 4 h and no accumulation of 4-AP was observed within 24 h. These findings demonstrate the potential of cocultivating bacteria with complementary metabolic capabilities to address both pharmaceutical contamination and transformation-product accumulation. Moreover, the highest 4-AP removal was achieved when M. lacus was present at a 100-fold higher cell density than Delftia P1, highlighting the importance of considering relative cell densities when designing co-cultures.
Open AccessCoupling Complementary Pathways in a Bacterial Co-culture Enables 4-Aminophenol Removal during Paracetamol Degradation
Pharmaceutical biodegradation can generate potentially toxic metabolites that persist after the parent compound has been removed, posing additional risks to aquatic environments. Microbial co-cultures offer a promising strategy to address this challenge by combining complementary metabolic capabilities to remove both pharmaceuticals and their harmful transformation products by coupling complementary degradation pathways. Here, we investigated a two-species co-culture combining the paracetamol-degrading bacterium Delftia P1 with Microbacterium lacus to enable subsequent 4-AP removal. While Delftia P1 efficiently degraded paracetamol, it accumulated 4-AP as a dead-end metabolite. M. lacus was selected to complement this metabolic limitation because its genome contains a homolog of sadB, a monooxygenase gene involved in 4-AP transformation. The relative abundance of the two strains strongly influenced 4-AP removal, with the highest efficiency achieved at a Delftia P1:M. lacus cell-density ratio of 1:100, corresponding to an OD600nm ratio of 1:10. At this ratio, the co-culture achieved complete removal of paracetamol and 4-AP within 6 and 24 h, respectively. Its capacity was tested in wastewater, where 100% of paracetamol were removed within 4 h and no accumulation of 4-AP was observed within 24 h. These findings demonstrate the potential of cocultivating bacteria with complementary metabolic capabilities to address both pharmaceutical contamination and transformation-product accumulation. Moreover, the highest 4-AP removal was achieved when M. lacus was present at a 100-fold higher cell density than Delftia P1, highlighting the importance of considering relative cell densities when designing co-cultures.
- 18 June 2026
- Published by Springer Nature in BIOspektrum
- Vol. 32 (4) , 475-477
Thermophile Kompostbakterien für gezielten Schadstoffabbau im Abwasser
- 18 June 2026
- Published by Springer Nature in BIOspektrum
- Vol. 32 (4) , 475-477
Thermophile Kompostbakterien für gezielten Schadstoffabbau im Abwasser
- Open Access
- 6 February 2026
- Published by Elsevier in Total Environment Microbiology
- Vol. 2 (1)
Pharmaceuticals residues lead to enrichment of Human, Animal, and Plant Pathogens in Wastewater
- 6 February 2026
- Published by Elsevier in Total Environment Microbiology
- Vol. 2 (1)
Open AccessPharmaceuticals residues lead to enrichment of Human, Animal, and Plant Pathogens in Wastewater
- Open Access
Pharmaceuticals residues lead to enrichment of Human, Animal, and Plant Pathogens in Wastewater
Wastewater forms a reservoir for diverse microbial pathogens, posing significant risks to public health and aquatic ecosystems. They further contain several pharmaceutical residues that can induce profound shifts in the wastewater microbiome. In this study, we assessed whether common non-antimicrobial pharmaceuticals such as pain killers and blood pressure regulators impact wastewater pathogen profiles. We spiked wastewater with caffeine (stimulant), atenolol (beta-blocker), paracetamol (analgesic), ibuprofen (anti-inflammatory) and enalapril (ACE-inhibitor), and monitored microbiome 16S rRNA gene profiles. We then matched species composition to a comprehensive database of human, animal, and plant pathogens. All pharmaceuticals significatively increased abundance and biodiversity for zoonotic, plant, and animal pathogens. These findings highlight that pharmaceutical contamination poses a biohazard risk by fostering pathogen growth. We call for a paired, continuous monitoring of chemical and biological pollutants and a more stringent removal of pharmaceutical residues from wastewater.
Open AccessPharmaceuticals residues lead to enrichment of Human, Animal, and Plant Pathogens in Wastewater
Wastewater forms a reservoir for diverse microbial pathogens, posing significant risks to public health and aquatic ecosystems. They further contain several pharmaceutical residues that can induce profound shifts in the wastewater microbiome. In this study, we assessed whether common non-antimicrobial pharmaceuticals such as pain killers and blood pressure regulators impact wastewater pathogen profiles. We spiked wastewater with caffeine (stimulant), atenolol (beta-blocker), paracetamol (analgesic), ibuprofen (anti-inflammatory) and enalapril (ACE-inhibitor), and monitored microbiome 16S rRNA gene profiles. We then matched species composition to a comprehensive database of human, animal, and plant pathogens. All pharmaceuticals significatively increased abundance and biodiversity for zoonotic, plant, and animal pathogens. These findings highlight that pharmaceutical contamination poses a biohazard risk by fostering pathogen growth. We call for a paired, continuous monitoring of chemical and biological pollutants and a more stringent removal of pharmaceutical residues from wastewater.
- Open Access
- 17 September 2025
- Published by Elsevier in Water Research
- Vol. 288 (Pt A) , 124629
Thermophilic compost bacteria as a promising approach for removal of diclofenac and related pharmaceuticals from wastewater
- 17 September 2025
- Published by Elsevier in Water Research
- Vol. 288 (Pt A) , 124629
Open AccessThermophilic compost bacteria as a promising approach for removal of diclofenac and related pharmaceuticals from wastewater
- Open Access
Compost bacteria as a promising new solution for degradation of diclofenac and related pharmaceuticals for water treatment processes
Diclofenac, a widely used pharmaceutical, poses a significant environmental problem due to its persistence in aquatic systems and resistance to conventional degradation processes. Mesophilic microorganisms, commonly employed in wastewater treatment, often struggle to break down diclofenac, necessitating alternative approaches for its removal. In this study, we investigated thermophilic compost microorganisms and their ability to degrade diclofenac. Compost communities were cultivated for 20 weeks at 50°C in a membrane bioreactor, with a continuous supply of 2 mg/L diclofenac as the sole carbon source. After two weeks, the microbial community steadily enhanced its ability to remove diclofenac, achieving removal rates up to 60%. The consortium demonstrated flexibility in the degradation of further pollutants, namely sulfamethoxazole, paracetamol, and ciprofloxacin, with changes in their community structure depending on the substrates. In addition, thermophilic isolates Chelatococcus sp. strain D3 and Mycobacterium sp. strain D1 were characterized and demonstrated variation in the first reaction of transforming diclofenac, which is the crucial step in mineralization of this pollutant, resulting in either 4-hydroxy-diclofenac or diclofenac-lactam, respectively. Furthermore, Chelotococcus sp. strain D3 demonstrated the capability to catalyze the biotransformation of diclofenac into 4-hydroxydiclofenac in treated wastewater. Notably, this transformation was effectively carried out even at lower temperatures (25 °C and 37°C). These results show that the use of thermophilic consortia can be applied for efficient bioremediation in wastewater treatment plants, specifically for compounds that mesophilic organisms degrade poorly.
Open AccessCompost bacteria as a promising new solution for degradation of diclofenac and related pharmaceuticals for water treatment processes
Diclofenac, a widely used pharmaceutical, poses a significant environmental problem due to its persistence in aquatic systems and resistance to conventional degradation processes. Mesophilic microorganisms, commonly employed in wastewater treatment, often struggle to break down diclofenac, necessitating alternative approaches for its removal. In this study, we investigated thermophilic compost microorganisms and their ability to degrade diclofenac. Compost communities were cultivated for 20 weeks at 50°C in a membrane bioreactor, with a continuous supply of 2 mg/L diclofenac as the sole carbon source. After two weeks, the microbial community steadily enhanced its ability to remove diclofenac, achieving removal rates up to 60%. The consortium demonstrated flexibility in the degradation of further pollutants, namely sulfamethoxazole, paracetamol, and ciprofloxacin, with changes in their community structure depending on the substrates. In addition, thermophilic isolates Chelatococcus sp. strain D3 and Mycobacterium sp. strain D1 were characterized and demonstrated variation in the first reaction of transforming diclofenac, which is the crucial step in mineralization of this pollutant, resulting in either 4-hydroxy-diclofenac or diclofenac-lactam, respectively. Furthermore, Chelotococcus sp. strain D3 demonstrated the capability to catalyze the biotransformation of diclofenac into 4-hydroxydiclofenac in treated wastewater. Notably, this transformation was effectively carried out even at lower temperatures (25 °C and 37°C). These results show that the use of thermophilic consortia can be applied for efficient bioremediation in wastewater treatment plants, specifically for compounds that mesophilic organisms degrade poorly.
- Open Access
- 12 July 2023
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 107 (17) , 5545-5554
Analyzing microbial communities and their biodegradation of multiple pharmaceuticals in membrane bioreactors
Pharmaceuticals are of concern to our planet and health as they can accumulate in the environment. The impact of these biologically active compounds on ecosystems is hard to predict, and information on their biodegradation is necessary to establish sound risk assessment. Microbial communities are promising candidates for the biodegradation of pharmaceuticals such as ibuprofen, but little is known yet about their degradation capacity of multiple micropollutants at higher concentrations (100 mg/L). In this work, microbial communities were cultivated in lab-scale membrane bioreactors (MBRs) exposed to increasing concentrations of a mixture of six micropollutants (ibuprofen, diclofenac, enalapril, caffeine, atenolol, paracetamol). Key players of biodegradation were identified using a combinatorial approach of 16S rRNA sequencing and analytics. Microbial community structure changed with increasing pharmaceutical intake (from 1 to 100 mg/L) and reached a steady-state during incubation for 7 weeks on 100 mg/L. HPLC analysis revealed a fluctuating but significant degradation (30–100%) of five pollutants (caffeine, paracetamol, ibuprofen, atenolol, enalapril) by an established and stable microbial community mainly composed of Achromobacter, Cupriavidus, Pseudomonas and Leucobacter. By using the microbial community from MBR1 as inoculum for further batch culture experiments on single micropollutants (400 mg/L substrate, respectively), different active microbial consortia were obtained for each single micropollutant. Microbial genera potentially responsible for degradation of the respective micropollutant were identified, i.e. Pseudomonas sp. and Sphingobacterium sp. for ibuprofen, caffeine and paracetamol, Sphingomonas sp. for atenolol and Klebsiella sp. for enalapril. Our study demonstrates the feasibility of cultivating stable microbial communities capable of degrading simultaneously a mixture of highly concentrated pharmaceuticals in lab-scale MBRs and the identification of microbial genera potentially responsible for the degradation of specific pollutants. Key points: • Multiple pharmaceuticals were removed by stable microbial communities. • Microbial key players of five main pharmaceuticals were identified.
- 12 July 2023
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 107 (17) , 5545-5554
Open AccessAnalyzing microbial communities and their biodegradation of multiple pharmaceuticals in membrane bioreactors
Pharmaceuticals are of concern to our planet and health as they can accumulate in the environment. The impact of these biologically active compounds on ecosystems is hard to predict, and information on their biodegradation is necessary to establish sound risk assessment. Microbial communities are promising candidates for the biodegradation of pharmaceuticals such as ibuprofen, but little is known yet about their degradation capacity of multiple micropollutants at higher concentrations (100 mg/L). In this work, microbial communities were cultivated in lab-scale membrane bioreactors (MBRs) exposed to increasing concentrations of a mixture of six micropollutants (ibuprofen, diclofenac, enalapril, caffeine, atenolol, paracetamol). Key players of biodegradation were identified using a combinatorial approach of 16S rRNA sequencing and analytics. Microbial community structure changed with increasing pharmaceutical intake (from 1 to 100 mg/L) and reached a steady-state during incubation for 7 weeks on 100 mg/L. HPLC analysis revealed a fluctuating but significant degradation (30–100%) of five pollutants (caffeine, paracetamol, ibuprofen, atenolol, enalapril) by an established and stable microbial community mainly composed of Achromobacter, Cupriavidus, Pseudomonas and Leucobacter. By using the microbial community from MBR1 as inoculum for further batch culture experiments on single micropollutants (400 mg/L substrate, respectively), different active microbial consortia were obtained for each single micropollutant. Microbial genera potentially responsible for degradation of the respective micropollutant were identified, i.e. Pseudomonas sp. and Sphingobacterium sp. for ibuprofen, caffeine and paracetamol, Sphingomonas sp. for atenolol and Klebsiella sp. for enalapril. Our study demonstrates the feasibility of cultivating stable microbial communities capable of degrading simultaneously a mixture of highly concentrated pharmaceuticals in lab-scale MBRs and the identification of microbial genera potentially responsible for the degradation of specific pollutants. Key points: • Multiple pharmaceuticals were removed by stable microbial communities. • Microbial key players of five main pharmaceuticals were identified.
- Open Access
- 14 April 2023
- Published by Wiley in Ecology Letters
- Vol. 26 (6) , 883-895
Functional diversity can facilitate the collapse of an undesirable ecosystem state
Biodiversity may increase ecosystem resilience. However, we have limited understanding if this holds true for ecosystems that respond to gradual environmental change with abrupt shifts to an alternative state. We used a mathematical model of anoxic–oxic regime shifts and explored how trait diversity in three groups of bacteria influences resilience. We found that trait diversity did not always increase resilience: greater diversity in two of the groups increased but in one group decreased resilience of their preferred ecosystem state. We also found that simultaneous trait diversity in multiple groups often led to reduced or erased diversity effects. Overall, our results suggest that higher diversity can increase resilience but can also promote collapse when diversity occurs in a functional group that negatively influences the state it occurs in. We propose this mechanism as a potential management approach to facilitate the recovery of a desired ecosystem state.
- 14 April 2023
- Published by Wiley in Ecology Letters
- Vol. 26 (6) , 883-895
Open AccessFunctional diversity can facilitate the collapse of an undesirable ecosystem state
Biodiversity may increase ecosystem resilience. However, we have limited understanding if this holds true for ecosystems that respond to gradual environmental change with abrupt shifts to an alternative state. We used a mathematical model of anoxic–oxic regime shifts and explored how trait diversity in three groups of bacteria influences resilience. We found that trait diversity did not always increase resilience: greater diversity in two of the groups increased but in one group decreased resilience of their preferred ecosystem state. We also found that simultaneous trait diversity in multiple groups often led to reduced or erased diversity effects. Overall, our results suggest that higher diversity can increase resilience but can also promote collapse when diversity occurs in a functional group that negatively influences the state it occurs in. We propose this mechanism as a potential management approach to facilitate the recovery of a desired ecosystem state.
- Open Access
Identification of microbial communities and their removal efficiency of multiple pharmaceutical micropollutants combined in Membrane-Bioreactors
Pharmaceuticals are of concern to our planet and health as they can accumulate in the environment. The impact of these biologically active compounds on ecosystems is hard to predict and information on their biodegradation is necessary to establish sound risk assessment. Microbial communities are promising candidates for the biodegradation of pharmaceuticals such as ibuprofen, but little is known yet about their degradation-capacity of multiple micropollutants at higher concentrations (100 mg/L). In this work, microbial communities were cultivated in lab-scale Membrane Bioreactors (MBRs) exposed to increasing concentrations of a mixture of six micropollutants (ibuprofen, diclofenac, enalapril, caffeine, atenolol, paracetamol). Key players of biodegradation were identified using a combinatorial approach of 16S rRNA sequencing and analytics. Microbial community structure changed with increasing pharmaceutical intake (from 1 mg/L to 100 mg/L) and reached a steady-state during incubation for 7 weeks on 100 mg/L. HPLC analysis revealed a fluctuating but significant degradation (30-100%) of five pollutants (caffeine, paracetamol, ibuprofen, atenolol, enalapril) by an established and stable microbial community mainly composed of Achromobacter , Cupriavidus , Pseudomonas and Leucobacter . By using the microbial community from MBR1 as inoculum for further batch culture experiments on single micropollutants (400 mg/L substrate, respectively), different active microbial consortia were obtained for each single micropollutant. Microbial genera potentially responsible for degradation of the respective micropollutant were identified, i.e. Pseudomonas sp. and Sphingobacterium sp. for ibuprofen, caffeine and paracetamol, Sphingomonas sp. for atenolol, and Klebsiella sp. for enalapril. Our study demonstrates the feasibility of cultivating stable microbial communities capable of degrading simultaneously a mixture of highly concentrated pharmaceuticals in lab-scale MBRs and the identification of microbial genera potentially responsible for the degradation of specific pollutants. Graphical
Open AccessIdentification of microbial communities and their removal efficiency of multiple pharmaceutical micropollutants combined in Membrane-Bioreactors
Pharmaceuticals are of concern to our planet and health as they can accumulate in the environment. The impact of these biologically active compounds on ecosystems is hard to predict and information on their biodegradation is necessary to establish sound risk assessment. Microbial communities are promising candidates for the biodegradation of pharmaceuticals such as ibuprofen, but little is known yet about their degradation-capacity of multiple micropollutants at higher concentrations (100 mg/L). In this work, microbial communities were cultivated in lab-scale Membrane Bioreactors (MBRs) exposed to increasing concentrations of a mixture of six micropollutants (ibuprofen, diclofenac, enalapril, caffeine, atenolol, paracetamol). Key players of biodegradation were identified using a combinatorial approach of 16S rRNA sequencing and analytics. Microbial community structure changed with increasing pharmaceutical intake (from 1 mg/L to 100 mg/L) and reached a steady-state during incubation for 7 weeks on 100 mg/L. HPLC analysis revealed a fluctuating but significant degradation (30-100%) of five pollutants (caffeine, paracetamol, ibuprofen, atenolol, enalapril) by an established and stable microbial community mainly composed of Achromobacter , Cupriavidus , Pseudomonas and Leucobacter . By using the microbial community from MBR1 as inoculum for further batch culture experiments on single micropollutants (400 mg/L substrate, respectively), different active microbial consortia were obtained for each single micropollutant. Microbial genera potentially responsible for degradation of the respective micropollutant were identified, i.e. Pseudomonas sp. and Sphingobacterium sp. for ibuprofen, caffeine and paracetamol, Sphingomonas sp. for atenolol, and Klebsiella sp. for enalapril. Our study demonstrates the feasibility of cultivating stable microbial communities capable of degrading simultaneously a mixture of highly concentrated pharmaceuticals in lab-scale MBRs and the identification of microbial genera potentially responsible for the degradation of specific pollutants. Graphical
- Open Access
- 26 June 2022
- Published by Wiley in Global Change Biology
- Vol. 28 (18) , 5575-5586
Predicting the effects of multiple global change drivers on microbial communities remains challenging
Microbial communities in many ecosystems are facing a broad range of global change drivers, such as nutrient enrichment, chemical pollution, and temperature change. These drivers can cause changes in the abundance of taxa, the composition of communities, and the properties of ecosystems. While the influence of single drivers is already described in numerous studies, the effect and predictability of multiple drivers changing simultaneously is still poorly understood. In this study, we used 240 highly replicable oxic/anoxic aquatic lab microcosms and four drivers (fertilizer, glyphosate, metal pollution, antibiotics) in all possible combinations at three different temperatures (20, 24, and 28°C) to shed light into consequences of multiple drivers on different levels of organization, ranging from species abundance to community and ecosystem parameters. We found (i) that at all levels of ecological organization, combinations of drivers can change the biological consequence and direction of effect compared to single drivers, (ii) that effects of combinations are further modified by temperature, (iii) that a larger number of drivers occurring simultaneously is often quite closely related to their effect size, and (iv) that there is little evidence that any of these effects are associated with the level of ecological organization of the state variable. These findings suggest that, at least in this experimental ecosystem approximating a stratified aquatic ecosystem, there may be relatively little scope for predicting the effects of combinations of drivers from the effects of individual drivers, or by accounting for the level of ecological organization in question, though there may be some scope for prediction based on the number of drivers that are occurring simultaneous. A priority, though also a considerable challenge, is to extend such research to consider continuous variation in the magnitude of multiple drivers acting together.
- 26 June 2022
- Published by Wiley in Global Change Biology
- Vol. 28 (18) , 5575-5586
Open AccessPredicting the effects of multiple global change drivers on microbial communities remains challenging
Microbial communities in many ecosystems are facing a broad range of global change drivers, such as nutrient enrichment, chemical pollution, and temperature change. These drivers can cause changes in the abundance of taxa, the composition of communities, and the properties of ecosystems. While the influence of single drivers is already described in numerous studies, the effect and predictability of multiple drivers changing simultaneously is still poorly understood. In this study, we used 240 highly replicable oxic/anoxic aquatic lab microcosms and four drivers (fertilizer, glyphosate, metal pollution, antibiotics) in all possible combinations at three different temperatures (20, 24, and 28°C) to shed light into consequences of multiple drivers on different levels of organization, ranging from species abundance to community and ecosystem parameters. We found (i) that at all levels of ecological organization, combinations of drivers can change the biological consequence and direction of effect compared to single drivers, (ii) that effects of combinations are further modified by temperature, (iii) that a larger number of drivers occurring simultaneously is often quite closely related to their effect size, and (iv) that there is little evidence that any of these effects are associated with the level of ecological organization of the state variable. These findings suggest that, at least in this experimental ecosystem approximating a stratified aquatic ecosystem, there may be relatively little scope for predicting the effects of combinations of drivers from the effects of individual drivers, or by accounting for the level of ecological organization in question, though there may be some scope for prediction based on the number of drivers that are occurring simultaneous. A priority, though also a considerable challenge, is to extend such research to consider continuous variation in the magnitude of multiple drivers acting together.